The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands.
about
Lifetime medical costs of obesity: prevention no cure for increasing health expenditureSelf-management education for patients with chronic obstructive pulmonary diseaseDevelopment, validity and responsiveness of the Clinical COPD QuestionnaireBurden of obstructive lung disease study in Tehran: Prevalence and risk factors of chronic obstructive pulmonary diseasePrevalence of COPD and tobacco smoking in Tunisia--results from the BOLD studyPrevalence of chronic obstructive pulmonary disease in rural women of Tamilnadu: implications for refining disease burden assessments attributable to household biomass combustionDirect costs of COPD in the U.S.: an analysis of Medical Expenditure Panel Survey (MEPS) data.Model for estimating the population prevalence of chronic obstructive pulmonary disease: cross sectional data from the Health Survey for England.Self-perceived symptoms and care needs of patients with severe to very severe chronic obstructive pulmonary disease, congestive heart failure or chronic renal failure and its consequences for their closest relatives: the research protocol.Using Exploratory Focus Groups to Inform the Development of Targeted COPD Self-Management Education DVDs for Rural Patients.Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review.Estimating and comparing incidence and prevalence of chronic diseases by combining GP registry data: the role of uncertaintyGeographic variations in risk: adjusting for unmeasured confounders through joint modeling of multiple diseases.Prevalence of chronic obstructive pulmonary disease in kocaeli: an industrialised city in Turkey.COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population.Simulation-based estimates of effectiveness and cost-effectiveness of smoking cessation in patients with chronic obstructive pulmonary disease.Lung function and blood markers of nutritional status in non-COPD aging men with smoking history: a cross-sectional study.Forecasts of COPD mortality in Australia: 2006-2025.Association between lung function and exacerbation frequency in patients with COPD.Chronic obstructive pulmonary disease, pollution, pulmonary vascular disease, transplantation, pleural disease, and lung cancer in AJRCCM 2001.Predictors of mortality in nursing home residents with advanced dementia.Self-management education for chronic obstructive pulmonary disease.Lung function profiles and aerobic capacity of adult cigarette and hookah smokers after 12 weeks intermittent training.Self-management education for patients with chronic obstructive pulmonary disease: a systematic review.Estimating health-adjusted life expectancy conditional on risk factors: results for smoking and obesity.Largely ignored: the impact of the threshold value for a QALY on the importance of a transferability factorPresent and future costs of COPD in Iceland and Norway: results from the BOLD studyRoflumilast (daliresp): a novel phosphodiesterase-4 inhibitor for the treatment of severe chronic obstructive pulmonary diseaseCOPD in Nonsmokers: Reports from the Tunisian Population-Based Burden of Obstructive Lung Disease StudySigns of progress in the Australian post-2000 COPD experience, but some old problems remain.Asthma and COPD: differences and similarities. With special reference to the usefulness of budesonide/formoterol in a single inhaler (Symbicort) in both diseases.Deaths from chronic obstructive pulmonary disease in France, 1979-2002: a multiple cause analysis.Airway disease: similarities and differences between asthma, COPD and bronchiectasis.Dynamic effects of smoking cessation on disease incidence, mortality and quality of life: The role of time since cessation.Optimizing safety of COPD treatments: role of the nurse practitioner.Is airway inflammation in chronic obstructive pulmonary disease (COPD) a risk factor for cardiovascular events?Secondhand Tobacco Smoke and COPD Risk in Smokers: A COPDGene Study Cohort Subgroup Analysis.Prevalence of airflow limitation in subjects undergoing comprehensive health examination in Japan: Survey of Chronic Obstructive pulmonary disease Patients Epidemiology in JapanOptimizing economic outcomes in the management of COPD.Effectiveness of the Assessment of Burden of COPD (ABC) tool on health-related quality of life in patients with COPD: a cluster randomised controlled trial in primary and hospital care.
P2860
Q21144656-594CAE9C-4B07-4618-9048-97FBE2C79B92Q24242905-1E40E379-F911-466E-BA95-6A69B4FADE1AQ24800304-89451C43-718E-4AC6-A430-BFA8F9C0E246Q28606967-7E419111-EF04-4562-A93F-56143BA47794Q28660851-5EF25A0F-9FBF-4E21-8710-982ACFCD878AQ28743113-A1CFB919-9D53-427E-8028-5FC3B0B583F8Q31082713-13469CAE-4705-4C1B-BAF9-40A5A4A02FCCQ31131160-5A0D3916-5165-4834-8107-C372BECC8387Q33332050-4FDA1FD0-8D93-41EA-8884-1B5001CB19D0Q33645434-D6780847-13E6-4A7E-90E2-0DFE15B6A433Q33796149-53569427-ED15-44ED-87C0-4AB0BC7A1A5BQ33846637-7A2BB6C8-D640-4597-BF76-58F38BBFA161Q33941937-7DA7D60A-A728-449C-A306-8962A69453F5Q33974119-938E5C3D-5998-4D9D-AB0F-9461C1C88F6FQ33977632-67783A64-8522-4500-B9D6-E3BD7BF058A1Q34031553-2A2D73A0-333B-4698-B628-A8B811400967Q34065973-50A774EF-2CCB-44B7-9CAA-345E1A643E82Q34165521-93EE1C85-B214-4EF0-A92C-E2534657EF46Q34432556-1CE55030-C56F-46DB-B149-06DD536C2640Q34550155-F04E3F42-C841-4647-91E6-469A6F70FB87Q34632143-F9B61943-54FA-4723-BBBD-0CDF312112D8Q35048644-0F025AEC-1FD8-4B73-A813-1D39706B227BQ35095823-45068FFC-1EA3-4F56-BA22-5BF71C4B6756Q35120107-1C4E0BB7-8243-4DD0-86BD-9D82B98FD9C1Q35131146-62C46FD9-E186-4DE0-9D5B-14DAC341DDD1Q35178018-2DF8AC98-273F-4514-8847-288848D59305Q35906562-1FD4DF54-4C7B-46F0-98AD-110A3A854515Q35958704-95CEDB6A-D8FE-4A3D-988C-94FD13158343Q35968539-D2B1591A-88A3-476A-91BC-41F62D32A762Q36048450-7DE1C9B1-B62B-4562-BC8D-17400653BE47Q36107742-C98033A3-9B02-4F23-989A-932872BAB5E6Q36237989-15F80EDC-B585-483C-9755-6E3BEC6C4FC4Q36371261-47874079-E0EF-4CEE-9045-CFE3F9F45BA3Q36494908-5F83B9D3-FFE2-4579-B512-60052E4C5D4EQ36642198-A9FC1178-3A3F-4F07-A3A8-3A7A740D0107Q36760107-A2F4E9F8-310D-4F1E-81E5-5ACEED50A69FQ36763923-DE435E0B-0368-426F-89C7-96F6D7D27599Q36858274-AF422F95-4731-41A4-86E9-3328D599650EQ36859405-ED2B41A2-6E84-45B2-ACAC-A70BA430087CQ37100837-1C90917F-2E54-4E9E-8C63-BC91F9AD3423
P2860
The impact of aging and smoking on the future burden of chronic obstructive pulmonary disease: a model analysis in the Netherlands.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
The impact of aging and smokin ...... l analysis in the Netherlands.
@en
type
label
The impact of aging and smokin ...... l analysis in the Netherlands.
@en
prefLabel
The impact of aging and smokin ...... l analysis in the Netherlands.
@en
P2093
P2860
P1476
The impact of aging and smokin ...... l analysis in the Netherlands.
@en
P2093
Feenstra TL
Hoogenveen RT
Rutten-van Mölken MP
Wouters EF
van Genugten ML
P2860
P304
P356
10.1164/AJRCCM.164.4.2003167
P407
P577
2001-08-01T00:00:00Z